Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.

@article{Lv2016ClinicalEO,
  title={Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.},
  author={Xuecheng Lv and Jinghua Li and Bingnan Yang},
  journal={Oncology reports},
  year={2016},
  volume={36 4},
  pages={2184-92}
}
The aim of this study was to verify whether anti-miR-101 participates in the treatment of hepatocellular carcinoma (HCC) as a small-molecule antitumor agent, and to explore the effect on phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Patients who received consecutive hepatectomies were followed-up, and miR-101 expressions in their tumor and… CONTINUE READING